OPCH Stock Recent News

OPCH, LMAT, C, FFIN and IBCP have been added to the Zacks Rank #1 (Strong Buy) List on March 4, 2025.

After reaching an important support level, Option Care Health, Inc. (OPCH) could be a good stock pick from a technical perspective. OPCH recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.

Call Start: 8:30 January 1, 0000 9:19 AM ET Option Care Health, Inc. (NASDAQ:OPCH ) Q4 2024 Earnings Conference Call February 26, 2025 8:30 AM ET Company Participants Nicole Maggio – Senior Vice President and Corporate Controller John Rademacher – President and Chief Executive Officer Mike Shapiro – Chief Financial Officer Conference Call Participants Matt Larew – William Blair Brian Tanquilut – Jefferies Lisa Gill – JPMorgan Pito Chickering – Deutsche Bank Constantine Davides – Citizens Joanna Gajuk – Bank of America Sarah Conrad – Goldman Sachs Operator Good day and thank you for standing by. Welcome to the Option Care Health Fourth Quarter 2024 Earnings Conference Call.

Option Care (OPCH) came out with quarterly earnings of $0.35 per share, beating the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.32 per share a year ago.

BANNOCKBURN, Ill., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the fourth quarter and full year ended December 31, 2024.

Option Care (OPCH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Quest Diagnostics, DaVita, Option Care Health and Addus HomeCare have been highlighted in this Industry Outlook article.

An aging global population and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DGX, DVA, OPCH and ADUS are well-poised to gain.

BANNOCKBURN, Ill., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2024.

BANNOCKBURN, Ill., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its third quarter ended September 30, 2024 on Wednesday, October 30, 2024 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day.